R&N Determination | Low Risk

Is Ketotifen Reasonable and Necessary?

Reasonable and Necessary determination guidance for Ketotifen (ZADITEN ketotifen 250microgram/mL eye drops bottle) on workers compensation and personal injury claims.

R&N Guide Source: TGA, FDA Updated April 2026

Whether Ketotifen (ZADITEN ketotifen 250microgram/mL eye drops bottle) is reasonable and necessary depends on the compensable injury, prescribing duration, and clinical justification. Ketotifen is classified as Low risk by AllMeds. It is S3 under the TGA in Australia. Claims professionals should assess whether the prescribing is directly related to the injury, within clinical guidelines for duration and dose, and not for a pre-existing condition.

Key Takeaways

  • Risk level: Low (1 points)
  • Schedule: S3 in Australia
  • Opioid: R&N determination required for prescribing beyond acute phase. Review against CDC/SIRA/NICE guidelines.
  • Key question: Is Ketotifen being prescribed for the compensable injury, or for a pre-existing or unrelated condition?

R&N Assessment: When Is Ketotifen Injury-Related?

Possibly Related - Requires Clinical Justification

  • Chronic pain from a workplace injury beyond 12 weeks
  • Pain management during active rehabilitation

Likely Not Reasonable and Necessary

  • Chronic pain unrelated to the compensable injury
  • Pre-existing pain conditions
  • Headaches or migraines without workplace causation

Duration and Dose Guidelines

Opioid R&N Thresholds by Jurisdiction

JurisdictionGuidelineR&N Threshold
AU - NSW (SIRA)SIRA Best Practice Opioid ManagementReview required beyond acute phase. Long-term use requires specialist justification.
AU - VIC (WorkSafe)WorkSafe Drugs of Dependence GuidelinesMonitoring required for all S8 opioids. Duration and dose should be regularly reviewed.
US (CDC)CDC Clinical Practice Guideline 2022Non-opioid therapies preferred. If opioids used, lowest effective dose for shortest duration. Reassess at 1-4 weeks.
UK (NICE)NICE NG193 Chronic PainDo not initiate opioids for chronic primary pain. Review ongoing opioid therapy regularly.

How to Make the R&N Determination

  1. Check injury relatedness: Is Ketotifen being prescribed for the compensable injury, or for a pre-existing or unrelated condition?
  2. Review clinical justification: Does the treating doctor's documentation explain why Ketotifen is necessary for this specific injury?
  3. Assess duration: Is the prescribing duration within clinical guidelines?
  4. Check for alternatives: Have safer or more appropriate treatments been trialled first?
  5. Review interactions: Is Ketotifen being combined with other medications that create additional risk?
  6. Document your determination: Record the R&N decision, rationale, and any actions taken in the claim file.

Check this medication against your full medication list

Run an automated R&N determination for Ketotifen against the compensable injury. AllMeds scores every medication as directly related, possibly related, or unrelated.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Related Resources

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.